Simulations Plus, Inc. (NASDAQ:SLP – Free Report) – Stock analysts at William Blair decreased their FY2026 earnings per share (EPS) estimates for shares of Simulations Plus in a research note issued on Wednesday, July 16th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.86 for the year, down from their prior forecast of $0.99. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.09 per share.
Simulations Plus (NASDAQ:SLP – Get Free Report) last issued its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.19. Simulations Plus had a positive return on equity of 11.62% and a negative net margin of 78.63%. The business had revenue of $20.36 million for the quarter, compared to analysts’ expectations of $22.83 million. During the same period last year, the business earned $0.27 EPS. The business’s revenue was up 9.8% on a year-over-year basis.
View Our Latest Analysis on SLP
Simulations Plus Trading Down 2.6%
Shares of NASDAQ:SLP opened at $12.46 on Thursday. The stock’s fifty day simple moving average is $23.45 and its two-hundred day simple moving average is $27.97. Simulations Plus has a 1-year low of $12.39 and a 1-year high of $42.11. The stock has a market cap of $250.82 million, a PE ratio of -3.96 and a beta of 0.83.
Insider Activity
In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the sale, the director directly owned 3,344,157 shares of the company’s stock, valued at $112,062,701.07. This trade represents a 0.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 19.40% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Simulations Plus
Large investors have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp increased its holdings in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after acquiring an additional 427 shares during the last quarter. Fifth Third Bancorp increased its holdings in Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company’s stock worth $36,000 after acquiring an additional 375 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Simulations Plus in the 4th quarter worth about $39,000. Tower Research Capital LLC TRC increased its holdings in Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company’s stock worth $72,000 after acquiring an additional 764 shares during the last quarter. Finally, AlphaQuest LLC increased its holdings in Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after acquiring an additional 2,243 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Read More
- Five stocks we like better than Simulations Plus
- High Flyers: 3 Natural Gas Stocks for March 2022
- Why Pure Storage Is a Core Investment for the AI Era
- What Are Dividend Contenders? Investing in Dividend Contenders
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- How to buy stock: A step-by-step guide for beginners
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.